Slovakia Country Drug Report 2018

Public expenditure

Understanding of the costs of drug-related actions is an important aspect of drug policy.

In Slovakia, drug policy documents have no associated budgets and estimates of the total executed expenditures are not made on a regular basis. One study estimated that total drug-related public expenditure represented 0.05 % of gross domestic product, or EUR 21.3 million, in 2006. Around 70 % of total public expenditure was allocated to public order and safety, while the rest was allocated to treatment, prevention, coordination, education and harm reduction.

The available information does not allow trends in drug-related public expenditures in Slovakia to be reported.


Slovakia main page

Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.